Evaluation of Therapeutic Effect of Targeting Nanobubbles Conjugated with NET-1 SiRNA by Shear Wave Elastography: an Study of Hepatocellular Carcinoma Bearing Mice Model

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2019 Sep 24

PMID 31544556

Citations 8

Authors

Haitao Shang

Bolin Wu

Xitian Liang

Yixin Sun

Xue Han

Lei Zhang

Qiucheng Wang

Wen Cheng

Affiliations

Soon will be listed here.

Abstract

This study aimed at investigating the tumor stiffness of hepatocellular carcinoma (HCC) bearing mice model in vivo to evaluate the therapeutic efficacy of targeting nanobubbles (TNBS) conjugated with NET-1 siRNA (NET-1 siRNA-TNBS). Also tested whether shear wave elastography (SWE) could demonstrate the pathological tumor changes and used to monitor therapeutic efficacy as a noninvasive method. The HCC bearing mice model was established by injecting human HCC cell line (HepG2). The mice were then divided into three groups randomly, and were treated with TNBS conjugated with NET-1 siRNA, TNBS conjugated with negative control gene, and saline as control. US-SWE was performed for three times. SWE values of all the tumors in three groups were increased with tumor growth. Emax was correlated with tumor size ( < .05). NET-1 gene (treatment group) significantly delayed the growth of tumor size compared to other two groups ( < .0001), showing a significantly increased Emax ( < .05). Immunohistochemical results showed that the NET-1 protein expression was significantly lower than the negative control and blank groups. In conclusion, TNBS conjugated with NET-1 siRNA inhibited tumor growth and prolonged the life of experimental animals. SWE provided a noninvasive and real time imaging method to detect the changes in tumor development.

Citing Articles

Tetraspanins in digestive‑system cancers: Expression, function and therapeutic potential (Review).

Chen K, Li Q, Li Y, Jiang D, Chen L, Jiang J Mol Med Rep. 2024; 30(5).

PMID: 39239742 PMC: 11411235. DOI: 10.3892/mmr.2024.13324.

Modifications of Nanobubble Therapy for Cancer Treatment.

Terlikowska K, Dobrzycka B, Terlikowski S Int J Mol Sci. 2024; 25(13).

PMID: 39000401 PMC: 11242568. DOI: 10.3390/ijms25137292.

Structural and Thermomagnetic Properties of Gallium Nanoferrites and Their Influence on Cells In Vitro.

Orzechowska M, Recko K, Klekotka U, Czerniecka M, Tylicki A, Satula D Int J Mol Sci. 2023; 24(18).

PMID: 37762487 PMC: 10532423. DOI: 10.3390/ijms241814184.

The Role of Small Interfering RNAs in Hepatocellular Carcinoma.

Chen F, Zhang W, Gao X, Yuan H, Liu K J Gastrointest Cancer. 2023; 55(1):26-40.

PMID: 37432548 DOI: 10.1007/s12029-023-00911-w.

RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC.

Shang H, Chen Y, Wang C, Zhang S, Wu B, Liang X Front Mol Biosci. 2022; 8:791331.

PMID: 35198599 PMC: 8859324. DOI: 10.3389/fmolb.2021.791331.

References

Baruteau J, Waddington S, Alexander I, Gissen P . Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects. J Inherit Metab Dis. 2017; 40(4):497-517. PMC: 5500673. DOI: 10.1007/s10545-017-0053-3. View

Ferrara K, Pollard R, Borden M . Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007; 9:415-47. DOI: 10.1146/annurev.bioeng.8.061505.095852. View

Geis N, Katus H, Bekeredjian R . Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des. 2012; 18(15):2166-83. DOI: 10.2174/138161212800099946. View

Li T, Xue Y, Wang G, Gu T, Li Y, Zhu Y . Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma. J Cancer. 2016; 7(10):1317-27. PMC: 4934040. DOI: 10.7150/jca.15157. View

Li J, Jamin Y, Boult J, Cummings C, Waterton J, Ulloa J . Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography. Br J Cancer. 2014; 110(7):1727-32. PMC: 3974089. DOI: 10.1038/bjc.2014.76. View

Lu Y, Kashida Y, Kulp S, Wang Y, Wang D, Hung J . Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Hepatology. 2007; 46(4):1119-30. DOI: 10.1002/hep.21804. View

Chammings F, Le-Frere-Belda M, Latorre-Ossa H, Fitoussi V, Redheuil A, Assayag F . Supersonic Shear Wave Elastography of Response to Anti-cancer Therapy in a Xenograft Tumor Model. Ultrasound Med Biol. 2016; 42(4):924-30. DOI: 10.1016/j.ultrasmedbio.2015.12.001. View

Hong C, Nam Y . Functional nanostructures for effective delivery of small interfering RNA therapeutics. Theranostics. 2014; 4(12):1211-32. PMC: 4183999. DOI: 10.7150/thno.8491. View

Bruix J, Gores G, Mazzaferro V . Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014; 63(5):844-55. PMC: 4337888. DOI: 10.1136/gutjnl-2013-306627. View

10.

Yoo J, Yu S, Na J, Kim K, Cho Y, Lee Y . Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. Int J Mol Sci. 2019; 20(6). PMC: 6471302. DOI: 10.3390/ijms20061292. View

11.

Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C . Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012; 263(3):673-7. DOI: 10.1148/radiol.12111317. View

12.

He S, Wei Y, Wang G, Xu Y, Zhou J, Zhang Y . Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo. Gastroenterol Res Pract. 2013; 2013:685150. PMC: 3838818. DOI: 10.1155/2013/685150. View

13.

Wu B, Qiao Q, Han X, Jing H, Zhang H, Liang H . Targeted nanobubbles in low-frequency ultrasound-mediated gene transfection and growth inhibition of hepatocellular carcinoma cells. Tumour Biol. 2016; 37(9):12113-12121. DOI: 10.1007/s13277-016-5082-2. View

14.

Ronot M, Di Renzo S, Gregoli B, Duran R, Castera L, Van Beers B . Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography. Eur Radiol. 2014; 25(2):346-58. DOI: 10.1007/s00330-014-3370-z. View

15.

Caskey C, Hu X, Ferrara K . Leveraging the power of ultrasound for therapeutic design and optimization. J Control Release. 2011; 156(3):297-306. PMC: 3243361. DOI: 10.1016/j.jconrel.2011.07.032. View

16.

Chammings F, Latorre-Ossa H, Le Frere-Belda M, Fitoussi V, Quibel T, Assayag F . Shear wave elastography of tumour growth in a human breast cancer model with pathological correlation. Eur Radiol. 2013; 23(8):2079-86. DOI: 10.1007/s00330-013-2828-8. View

17.

El Kaffas A, Bekah D, Rui M, Kumaradas J, Kolios M . Investigating longitudinal changes in the mechanical properties of MCF-7 cells exposed to paclitaxol using particle tracking microrheology. Phys Med Biol. 2013; 58(4):923-36. DOI: 10.1088/0031-9155/58/4/923. View

18.

Falou O, Sadeghi-Naini A, Prematilake S, Sofroni E, Papanicolau N, Iradji S . Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography. Transl Oncol. 2013; 6(1):17-24. PMC: 3573650. DOI: 10.1593/tlo.12412. View

19.

Elyas E, Papaevangelou E, Alles E, Erler J, Cox T, Robinson S . Correlation of Ultrasound Shear Wave Elastography with Pathological Analysis in a Xenografic Tumour Model. Sci Rep. 2017; 7(1):165. PMC: 5427848. DOI: 10.1038/s41598-017-00144-5. View

20.

Chen L, Wang Z, Zhan X, Li D, Zhu Y, Zhu J . Association of NET-1 gene expression with human hepatocellular carcinoma. Int J Surg Pathol. 2007; 15(4):346-53. DOI: 10.1177/1066896907306083. View